SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+9.29%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$392M
AUM Growth
+$392M
(+21%)
Cap. Flow
+$47M
Cap. Flow
% of AUM
12%
Top 10 Holdings %
Top 10 Hldgs %
39.92%
Holding
132
New
31
Increased
30
Reduced
24
Closed
25
Top Buys
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
Novartis
NVS
|
$19M |
| 3 |
Pfizer
PFE
|
$13.3M |
| 4 |
SHPG
Shire pic
SHPG
|
$13.1M |
| 5 |
CELG
Celgene Corp
CELG
|
$8.71M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$13.8M |
| 2 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$13M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$11.2M |
| 4 |
Merck
MRK
|
$9.85M |
| 5 |
AKAO
Achaogen, Inc.
AKAO
|
$7.93M |
Sector Composition
| 1 | Healthcare | 77.61% |
| 2 | Technology | 5.72% |
| 3 | Communication Services | 2.6% |
| 4 | Industrials | 2.35% |
| 5 | Consumer Discretionary | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Air Products & Chemicals
APD
$64.8B
| – | – |
-21,165
| Closed | -$3.04M |
|
|
CLCD
127
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| – | – |
-358,000
| Closed | -$13M |
|
|
IMDZ
128
DELISTED
Immune Design Corp.
IMDZ
| – | – |
-103,000
| Closed | -$567K |
|
|
NDRM
129
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| – | – |
-175,951
| Closed | -$3.91M |
|
130
Arbutus Biopharma
ABUS
$753M
| – | – |
-22,000
| Closed | -$54K |
|
|
RXDX
131
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-22,065
| Closed | -$117K |
|